Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07854483) titled 'A Phase 1b Study of C-CAR168 in Participants With Systemic Sclerosis (SSc)' on Sept. 27.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: AbelZeta Inc.
Condition:
Systemic Sclerosis (SSc)
Systemic Sclerosis
Systemic Sclerosis (Scleroderma)
Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria
Systemic Sclerosis Pulmonary
Systemic Sclerosis With Lung Involvement
Intervention:
Biological: C-CAR168
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: March ...